Roche Hldgs (GENUS) Dividend yield

 Price  341.95
 Dividend  9.10
 Earnings  18.79
 Cash-flow  21.24
 Book value  42.74
 Equity  40.50

Roche Hldgs (GENUS) is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Roche Hldgs (GENUS) is a company from Switzerland, and his stocks are publicly traded.

Roche Hldgs (GENUS) paid a total dividend of 6,306 million CHF last year, for a market value of 236,971 millions (Market Cap 237,014 millions). Dividend per share of Roche Hldgs (GENUS) is 9.10 CHF, and his stock market price 341.95 CHF.

According to the chart below, where dividend yield is displayed, Roche Hldgs (GENUS) has a dividend yield of 2.66%, which is higher than the amount offered by both the market average and companies from Switzerland. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare Roche Hldgs (GENUS) dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Switzerland.

Dividend yield of Roche Hldgs (GENUS)

Roche Hldgs (GENUS) Dividend Payout

About the ability of Roche Hldgs (GENUS) to maintain his current dividend of CHF 9.10 per share, an amount that accounts for 2.66%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Roche Hldgs (GENUS) payout on ernings is currently 48.43%, which is higher than the market average, and companies of Health Care industry, which are 39.27% and 31.41% respectively. Both figures show that Roche Hldgs (GENUS) can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Roche Hldgs (GENUS) is CHF 21.24 per share, which is higher than the dividend per share paid by the company of CHF 9.10, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Roche Hldgs (GENUS), compared againt world market average, Switzerland companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Roche Hldgs (GENUS) payout

Roche Hldgs (GENUS) Dividend History

Year Yield  CHF  Paypout  Shares* 

*In millions

Roche Hldgs (GENUS) Stock performance

Finally, last moth Roche Hldgs (GENUS) showed a return of -7.00% compared to a worldwide -1.33% average, and a -3.33% of Health Care firms. Over the last year, the company obtained a 8.50% versus a worldwide performance of a 31.58%. More detailed information can be seen in the following graph for Switzerland and Pharmaceuticals and Biotechnology firms.

Roche Hldgs (GENUS) stock and market return